StockData
Intensity Therapeutics, Inc. logo

Intensity Therapeutics, Inc. (INTS) stock

INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.28+0.19 (+6.15%)

Close on Nov 11, 2026Market cap $10.71MP/E –Yield –

Intensity Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Intensity Therapeutics's market cap was $9.66M on Nov 11, 2026, against $19.59M a year earlier. Over the last 4 years it ranged from $4.23M to $117.49M, with a median of $20.32M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.66M-52.0%
2025Dec 31, 2025$20.13M-17.5%
2024Dec 31, 2024$24.40M-79.2%
2023Dec 29, 2023$117.49M–

More Intensity Therapeutics figures

See a number that looks wrong?